Inspire Enterprise Value Over E B I T D A from 2010 to 2024

INSP Stock  USD 157.79  1.35  0.86%   
Inspire Medical Enterprise Value Over EBITDA yearly trend continues to be relatively stable with very little volatility. Enterprise Value Over EBITDA is likely to drop to -151.23. During the period from 2010 to 2024, Inspire Medical Enterprise Value Over EBITDA destribution of quarterly values had r-value of (0.88) from its regression line and median of (22.26). View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(144.03)
Current Value
(151.23)
Quarterly Volatility
59.55828934
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Inspire Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inspire Medical's main balance sheet or income statement drivers, such as Interest Income of 19 M, Depreciation And Amortization of 1.7 M or Interest Expense of 0.0, as well as many indicators such as Price To Sales Ratio of 9.06, Dividend Yield of 0.0 or PTB Ratio of 9.89. Inspire financial statements analysis is a perfect complement when working with Inspire Medical Valuation or Volatility modules.
  
Check out the analysis of Inspire Medical Correlation against competitors.

Latest Inspire Medical's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Inspire Medical Systems over the last few years. It is Inspire Medical's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inspire Medical's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

Inspire Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean(60.84)
Coefficient Of Variation(97.90)
Mean Deviation51.48
Median(22.26)
Standard Deviation59.56
Sample Variance3,547
Range140
R-Value(0.88)
Mean Square Error883.78
R-Squared0.77
Significance0.000018
Slope(11.68)
Total Sum of Squares49,661

Inspire Enterprise Value Over E B I T D A History

2024 -151.23
2023 -144.03
2022 -155.85
2021 -152.89
2020 -86.3
2019 -56.88
2018 -29.35

About Inspire Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Inspire Medical income statement, its balance sheet, and the statement of cash flows. Inspire Medical investors use historical funamental indicators, such as Inspire Medical's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Inspire Medical investors may use each financial statement separately, they are all related. The changes in Inspire Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Inspire Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Inspire Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Inspire Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA(144.03)(151.23)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Tools for Inspire Stock Analysis

When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.